Header Logo

Connection

Bette Caan to Risk Assessment

Back to Details
This is a "connection" page, showing publications Bette Caan has written about Risk Assessment.
Bette Caan
Connection Strength
1.355
Risk Assessment
  1. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
    View in: PubMed
    Score: 0.106
  2. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
    View in: PubMed
    Score: 0.101
  3. Postdiagnosis Weight Change and Survival Following a Diagnosis of Early-Stage Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):44-50.
    View in: PubMed
    Score: 0.099
  4. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.090
  5. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013 May 01; 105(9):616-23.
    View in: PubMed
    Score: 0.078
  6. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.076
  7. Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol. 2012 May 01; 30(13):1492-7.
    View in: PubMed
    Score: 0.073
  8. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.072
  9. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.065
  10. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19; 100(22):1581-91.
    View in: PubMed
    Score: 0.058
  11. Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst. 2006 May 17; 98(10):700-7.
    View in: PubMed
    Score: 0.049
  12. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
    View in: PubMed
    Score: 0.033
  13. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.030
  14. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology. 2018 06; 154(8):2152-2164.e19.
    View in: PubMed
    Score: 0.027
  15. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006 Jul 05; 296(1):79-86.
    View in: PubMed
    Score: 0.025
  16. Risk of Mortality According to Body Mass Index and Body Composition Among Postmenopausal Women. Am J Epidemiol. 2015 Oct 01; 182(7):585-96.
    View in: PubMed
    Score: 0.023
  17. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015 Aug; 1(5):611-21.
    View in: PubMed
    Score: 0.023
  18. A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.023
  19. Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst. 2014 Jan; 106(1):djt359.
    View in: PubMed
    Score: 0.020
  20. African American race but not genome-wide ancestry is negatively associated with atrial fibrillation among postmenopausal women in the Women's Health Initiative. Am Heart J. 2013 Sep; 166(3):566-72.
    View in: PubMed
    Score: 0.020
  21. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
    View in: PubMed
    Score: 0.019
  22. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat. 2011 Sep; 129(2):549-56.
    View in: PubMed
    Score: 0.017
  23. Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer. 2010 Dec 04; 10:670.
    View in: PubMed
    Score: 0.017
  24. Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2011 Jan; 125(2):519-27.
    View in: PubMed
    Score: 0.016
  25. Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol. 2009 Apr 15; 169(8):977-89.
    View in: PubMed
    Score: 0.015
  26. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 2009 May; 58(5):661-7.
    View in: PubMed
    Score: 0.014
  27. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med. 2008 Mar 18; 148(6):419-26.
    View in: PubMed
    Score: 0.014
  28. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
    View in: PubMed
    Score: 0.014
  29. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb; 19(1):61-109.
    View in: PubMed
    Score: 0.014
  30. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
    View in: PubMed
    Score: 0.013
  31. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.
    View in: PubMed
    Score: 0.012
  32. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006 Jun 15; 118(12):3140-6.
    View in: PubMed
    Score: 0.012
  33. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006 May 23; 113(20):2425-34.
    View in: PubMed
    Score: 0.012
  34. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006 Apr 12; 295(14):1647-57.
    View in: PubMed
    Score: 0.012
  35. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control. 2005 Nov; 16(9):1021-33.
    View in: PubMed
    Score: 0.012
  36. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
    View in: PubMed
    Score: 0.012
  37. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1224-9.
    View in: PubMed
    Score: 0.011
  38. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
    View in: PubMed
    Score: 0.011
  39. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):285-92.
    View in: PubMed
    Score: 0.010
  40. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control. 2000 Jan; 11(1):1-8.
    View in: PubMed
    Score: 0.008

© 2024 Kaiser Permanente